	Systematic review of spectral computed tomography quantitative parameters for predicting EGFR mutation status in non-small cell lung cancer. Quant Imaging Med Surg Li J, Gao L, Jiao X, Xia F, Jia N, Huang Y, Wang S, Sun S, Huang S. PMID: 42861248 [PubMed]
	Diagnostic performance of spectral CT quantitative parameters in predicting spread through air spaces of lung adenocarcinoma. Quant Imaging Med Surg Chen W, Xia Z, Ma J, Liu W, Cui B, Zheng S, Wan Q, Li Q, Wu Y, Chen T, Ye T, Zhu Y, Li X. PMID: 42861138 [PubMed]
	A study to learn how well HER3-DXd (patritumab deruxtecan) works and how safe it is in people with previously treated non-small-cell lung cancer that has a mutation in the EGFR gene: a plain language summary of the HERTHENA-Lung01 study. Future Oncol Yu HA, Goto Y, Jänne PA. PMID: 42860885 [PubMed - as supplied by publisher]
	Lymph node yield and station count in early robot-assisted versus established video-assisted resection for non-small cell lung cancer: higher total node counts reflect yield per sampled station. J Robot Surg Kim JD, Lee YS, Yang JW. PMID: 42860470 [PubMed - indexed for MEDLINE]
	Metastatic Lung Adenocarcinoma to the Uterus Mimicking a Primary Uterine Malignancy: A Case Report. Cancer Rep (Hoboken) Sun P, Wang Y. PMID: 42860291 [PubMed - indexed for MEDLINE]
	Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study. Cureus Kumar Y, Subramanian BV, Deepthi GV, Das P, Bonala SR. PMID: 42859818 [PubMed]
	AI-Assisted Volumetric Comparison of Parenchyma-Sparing Effect in Robotic Segmentectomy vs Lobectomy. JSLS Sayan M, Aytekin Celik I, Fattahov M, Artiran B, Temirkaynak FO, Celik A. PMID: 42859444 [PubMed - indexed for MEDLINE]
	Tissue-specific variability in protein expression of cytochrome P450 and glutathione S-transferase isoenzymes in non-small cell lung carcinoma. Arh Hig Rada Toksikol K, O, Çelik S, Demira, B, , Ada AO. PMID: 42859408 [PubMed - indexed for MEDLINE]
	Early postoperative body-composition trajectories and exploratory ratio-defined phenotypes after laryngectomy for laryngeal cancer: a prospective cohort study. Support Care Cancer Chen F, Gui Y, Zheng Y, Wang L, Wu Z, Huang Q. PMID: 42859280 [PubMed - indexed for MEDLINE]
	Prognostic implications of asymptomatic COVID-19 infection in non-small-cell lung cancer patients receiving active anticancer treatment: an observational study with prospective survival follow-up. Cancer Treat Res Commun Wong SY, Chan SY, Chan SK, Chau TC, Tam YH, Chan JFW, Ip CY, Choi HC, Ng SC, Yuen KK, Lee VH. PMID: 42858728 [PubMed - as supplied by publisher]
	Daidzein derivatives as potential inhibitors of mutant EGFR in non-small cell lung cancer: A computational study supported by molecular docking, DFT, molecular dynamics simulations, and MM/PBSA techniques. Comput Methods Programs Biomed Munir F, Hussain K, Zhao G, Zhang J. PMID: 42858544 [PubMed - as supplied by publisher]
	Efficacy and Safety of CyberKnife-Based SBRT and Linear Accelerator-Based IMRT/VMAT for Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Propensity Score-Matched Real-World Analysis. Technol Cancer Res Treat Sun S, Duan Y, Yang G, Xiao H, Chen X, Wang Z, Ma J, Su K, Chen C, Tong X, Xiong Y, Yang X, Li M. PMID: 42857984 [PubMed - indexed for MEDLINE]
	Comparative Efficacy of First-Line versus Further-Line Icotinib Therapy in Advanced Lung Adenocarcinoma: A Real-World Cohort Study. Onco Targets Ther Zhang X, Wang J, Chen J. PMID: 42857742 [PubMed]
	Natural metabolites targeting macrophage polarization for non-small cell lung cancer therapy: a review of mechanisms and applications based on chemical classification. Front Pharmacol Zhang Y, Liu L, Dai X, Yan H, Lei X, Yang H. PMID: 42857493 [PubMed]
	PI3K/AKT/mTOR signaling at the immune checkpoint interface in lung cancer: molecular mechanisms, Tumor-Immune remodeling, therapeutic resistance, and emerging treatment strategies. Front Cell Dev Biol Jin H, Yang F, Zong S, Sun W. PMID: 42857335 [PubMed]
	Preoperative risk stratification for pulmonary complications after neoadjuvant therapy and esophagectomy in locally advanced esophageal squamous cell carcinoma: a retrospective cohort study. Front Oncol Lv H, Wang M, Zhu M, Lu T, Ma Y, Han R. PMID: 42857285 [PubMed]
	An explainable nomogram incorporating systemic inflammatory indicators and radiation esophagitis for risk assessment of radiation pneumonitis in lung cancer. Front Immunol Li J, Li C, Liu J, Wang C, Zhao Y, Ge A, Dong Y, Yang X. PMID: 42857233 [PubMed - indexed for MEDLINE]
	Not all major pathological responses are equal: prognostic heterogeneity and risk stratification after neoadjuvant chemoimmunotherapy in resectable NSCLC. Front Immunol Lin J, Xu H, Tang J, He C, Li P, Lin X, Wu J, Huang Z, Huang C, Xie Z, Wu H. PMID: 42857111 [PubMed - indexed for MEDLINE]
	Efficacy and safety of induction benmelstobart plus anlotinib and chemotherapy followed by concurrent chemoradiotherapy and benmelstobart consolidation versus concurrent chemoradiotherapy followed by benmelstobart consolidation in patients with unresectable stage III NSCLC: a randomized, controlled, multicenter phase II trial protocol (BEAM-LUNG). Front Immunol Song Z, Ma S, Zhang X, Liu X. PMID: 42857095 [PubMed - indexed for MEDLINE]
	Adoptive cell therapy in lung cancer: progress, challenges, and prospects. Chin Med J Pulm Crit Care Med Li J, Tong C, Chen Y, Zhu B. PMID: 42856948 [PubMed]

Articles 1 - 20 / 163665

Page 1 of 8184



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy